Revelation Biosciences, Inc. filed its 10-K on Mar 30, 2023 for the period ending Dec 31, 2022. In this report its auditor, Baker Tilly, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.154 USD | -1.19% | +5.08% | -85.66% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-85.66% | 3.56M | |
+2.58% | 42.75B | |
+47.70% | 41.61B | |
+12.07% | 41.34B | |
-8.83% | 26.59B | |
+7.82% | 25.49B | |
-22.52% | 18.12B | |
+31.13% | 12.24B | |
-1.40% | 11.76B | |
+9.00% | 11B |
- Stock Market
- Equities
- REVB Stock
- News Revelation Biosciences, Inc.
- Revelation Biosciences, Inc. Auditor Raises 'Going Concern' Doubt